
Supplier Advantages: BioZ Non-Invasive Hemodynamic Monitoring System, developed by MEDEAN, boasts advantages such as being non-invasive, easy to operate, continuous monitoring, high accuracy, low cost, and fast results. The system provides real-time, dynamic hemodynamic parameters, supporting personalized treatment decisions while significantly reducing costs for both hospitals and patients. Since its establishment in 2005, MEDEAN has accumulated extensive experience in impedance analysis technology, becoming a leader in the non-invasive hemodynamic monitoring industry. Its products are widely used in thousands of hospitals across China and have participated in multiple national key research projects. MEDEAN is now seeking overseas partners.
| Published by | MEDEAN | Department | -- |
|---|---|---|---|
| Region | Guangdong,China | Budget | -- |
| Validity | Long-term | ||
1. Requirements Description
Seeking overseas partners, interested parties are welcome to communicate.
2. Product Introduction

1. Product Name
BioZ Non-Invasive Hemodynamic Monitoring System
2. Product Selling Points
- First, it is completely non-invasive and easy to operate, with no related examination risks for patients. A single nurse can complete all operations, and the learning curve is short.
- Second, continuous hemodynamic monitoring can be achieved. The system operates without the need for staff intervention and can provide continuous monitoring from a few minutes to several hours, which is crucial for clinical diagnosis and treatment. When doctors evaluate drug efficacy or develop and validate treatment plans, they can use continuous data for before-and-after comparative analysis. The BioZ system offers real-time, dynamic, and continuous hemodynamic parameters for clinical use, enhancing the precision of personalized treatment decisions and the timeliness of clinical interventions. Invasive monitoring carries a risk of infection, and monitoring methods based on principles like ultrasound are limited by their technical nature and cannot achieve such continuous monitoring.
- Third, it rivals the accuracy of traditional invasive methods. According to Mr. Li Jun, the monitoring accuracy of the BioZ system can be comparable to invasive monitoring and can almost completely replace invasive monitoring in functional hemodynamic monitoring.
- Fourth, low cost. The cost of invasive hemodynamic monitoring is high, with catheter prices reaching thousands of yuan and being for single use only. However, the non-invasive monitoring method of the BioZ system does not require catheters, and the cost of its sensor electrodes is only 1/20 that of invasive catheters, significantly reducing hospitals' procurement costs and patients' medical expenses.
- Fifth, the results are issued quickly. According to Mr. Li Jun, the BioZ system takes only 3 to 5 minutes from patient examination to obtaining the report. In contrast, if invasive monitoring is performed, this time might barely be enough to complete the sterilization process, and the subsequent catheter placement could take more than ten minutes or even half an hour, making it quite time-consuming. By comparison, the BioZ system can better "save time" when dealing with critically ill or emergency patients, aiding in timely diagnosis and treatment.
3. Company Introduction
-MEDEAN, founded in 2005, is a national high-tech enterprise integrating research and development, production, manufacturing, sales, and service. After nearly 20 years of development, it has rapidly risen to prominence with its strong R&D capabilities and mature technology in the field of impedance analysis.
-MEDEAN Medical's 1.0 era products, the BioZ® and PeriCare® series of non-invasive hemodynamic monitoring products, have been widely used in hospitals across China, with over a thousand users currently. Collaborating with multiple domestic scientific research institutions, MEDEAN has participated in several national key projects, including manned spaceflight applications and the collection of big data on hemodynamic constants for Chinese people. MEDEAN Medical has become an industry leader in non-invasive hemodynamic monitoring.